Healthcare provider profile · identity verified

Khadijah B Ahmad, MD

Family Practice · WISC RAPIDS, WI · NPI 1386756534

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	820	215
Levothyroxine Sodium	Levothyroxine Sodium	510	129
Amlodipine Besylate	Amlodipine Besylate	430	117
Lisinopril	Lisinopril	321	80
Losartan Potassium	Losartan Potassium	300	80
Metoprolol Succinate	Metoprolol Succinate	275	81
Omeprazole	Omeprazole	252	60
Sertraline Hcl	Sertraline Hcl	208	49
Rosuvastatin Calcium	Rosuvastatin Calcium	207	62
Metoprolol Tartrate	Metoprolol Tartrate	199	46
Glipizide	Glipizide	171	34
Albuterol Sulfate Hfa	Albuterol Sulfate	165	50
Ezetimibe	Ezetimibe	158	39
Alendronate Sodium	Alendronate Sodium	152	40
Warfarin Sodium	Warfarin Sodium	150	32
Jardiance	Empagliflozin	132	15
Gabapentin	Gabapentin	126	24
Eliquis	Apixaban	122	20
Furosemide	Furosemide	122	38
Hydrochlorothiazide	Hydrochlorothiazide	119	35
Clopidogrel	Clopidogrel Bisulfate	117	30
Metformin Hcl	Metformin Hcl	116	31
Pantoprazole Sodium	Pantoprazole Sodium	113	33
Potassium Chloride	Potassium Chloride	113	33
Buspirone Hcl	Buspirone Hcl	106	25
Pravastatin Sodium	Pravastatin Sodium	101	22
Simvastatin	Simvastatin	91	23
Famotidine	Famotidine	85	18
Hydralazine Hcl	Hydralazine Hcl	83	21
Fluticasone Propionate	Fluticasone Propionate	72	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	70	14
Glipizide Er	Glipizide	70	12
Allopurinol	Allopurinol	66	19
Trulicity	Dulaglutide	66	11
Trazodone Hcl	Trazodone Hcl	62	21
Escitalopram Oxalate	Escitalopram Oxalate	58	19
Fluoxetine Hcl	Fluoxetine Hcl	56	12
Venlafaxine Hcl Er	Venlafaxine Hcl	55	suppressed
Xarelto	Rivaroxaban	54	suppressed
Ozempic	Semaglutide	52	12
Metformin Hcl Er	Metformin Hcl	50	15
Paroxetine Hcl	Paroxetine Hcl	50	13
Tramadol Hcl	Tramadol Hcl	50	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	suppressed
Carvedilol	Carvedilol	44	13
Methocarbamol	Methocarbamol	44	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Myrbetriq	Mirabegron	43	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	42	suppressed
Atenolol	Atenolol	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	37	suppressed
Bupropion Xl	Bupropion Hcl	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Klor-Con M20	Potassium Chloride	35	suppressed
Nitroglycerin	Nitroglycerin	35	22
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Chlorthalidone	Chlorthalidone	33	suppressed
Nystatin	Nystatin	32	17
Montelukast Sodium	Montelukast Sodium	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	suppressed
Amoxicillin	Amoxicillin	28	19
Donepezil Hcl	Donepezil Hcl	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Roflumilast	Roflumilast	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Cephalexin	Cephalexin	24	21
Pregabalin	Pregabalin	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	13
Enalapril Maleate	Enalapril Maleate	22	suppressed
Felodipine Er	Felodipine	22	suppressed
Fenofibrate	Fenofibrate	22	suppressed
Loperamide	Loperamide Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Duloxetine Hcl	Duloxetine Hcl	21	suppressed
Lansoprazole	Lansoprazole	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Baclofen	Baclofen	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Indapamide	Indapamide	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	18
Propranolol Hcl	Propranolol Hcl	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Glimepiride	Glimepiride	14	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Digoxin	Digoxin	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error